Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Return on Capital Employed (2021 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Return on Capital Employed for 3 consecutive years, with 0.33% as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Return on Capital Employed rose 3.0% year-over-year to 0.33%, compared with a TTM value of 0.33% through Sep 2023, up 3.0%, and an annual FY2022 reading of 0.28%, up 12.0% over the prior year.
  • Return on Capital Employed was 0.33% for Q3 2023 at Terns Pharmaceuticals, down from 0.26% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.22% in Q2 2021 and bottomed at 0.37% in Q2 2022.
  • Average Return on Capital Employed over 3 years is 0.29%, with a median of 0.3% recorded in 2021.
  • The sharpest move saw Return on Capital Employed dropped -15bps in 2022, then grew 11bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.3% in 2021, then rose by 10bps to 0.27% in 2022, then decreased by -24bps to 0.33% in 2023.
  • Business Quant data shows Return on Capital Employed for TERN at 0.33% in Q3 2023, 0.26% in Q2 2023, and 0.25% in Q1 2023.